Notice Number: NOT-HD-16-036

Key Dates
Release Date: December 14, 2016

Issued by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute on Dental and Craniofacial Research (NIDCR)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)

Purpose

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), with other NIH Institutes and Centers (ICs) listed above, announces that PAR-16-106 "Rapid Assessment of Zika Virus (ZIKV) Complications (R21)" is being reissued. The reissued FOA will use standard application due dates, and the timeframes for review, council and award dates will now align with standard NIH practices.

With the reissuance of the FOA, Zika-related R21 applications will no longer be accepted on a rolling basis. The last day to submit a "rapid" R21 under PAR-16-106 will be January 13, 2017. After that date, R21 applications may be submitted to the reissued FOA on standard due dates.

The goal of PAR-16-106 had been to respond quickly to the public health emergency, by reviewing applications rapidly, and making timely awards to support much needed projects. As a result of this effort grants were awarded to support a number of highly meritorious projects that were particularly urgent or time-sensitive. The participating (ICs) intend to continue their commitment to supporting Zika research, but applications will no longer be accepted on a rolling basis.

Not every NIH Institute or Office that had participated in PAR-16-106 will participate in the re-issued FOA, but there are other FOAs to support Zika projects related to their research interests and priorities. For example, PA-16-141 invites applications on the "Development of Anima Models and Related Biological Materials for Research (R21).” NOT-HL-16-466 lists FOAs addressing Zika virus related blood supply safety and transfusion research.

Other Zika-related FOAs may be found by searching the NIH Guide for Grants and Contracts at: http://grants.nih.gov/funding/index.htm. In addition, Zika-related applications may also be submitted in response to one of the NIH-wide parent FOAs.

Potential applicants are strongly encouraged to contact Scientific/Research staff before submitting an application to determine whether or not the proposed work is within the intended scope of this program.

Inquiries

Please direct all inquiries to:

Nahida Chakhtoura MD, MsGH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-435-6872
Email: [email protected]

Julia L. Zehr, Ph. D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-1617
Email: [email protected]

May Wong, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone:  301-496-1431
Email:  [email protected]

Lillian Shum, PhD
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-594-0618
Email:  [email protected]

Mark Challberg, PhD
National Institute of Allergy and Infectious Diseases (NIAID)
Phone: 301-496-7453
Email: [email protected]

George McKie, DVM, PhD
National Eye Institute (NEI)
Telephone: 301-435-8152
Email: [email protected]

eila Selimovic, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-451-4577
Email:  [email protected] 

Simone Glynn, M.D., M.P.H.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0065
Email: [email protected]

Stephanie Murphy, V.M.D., Ph.D.
Office of Research Infrastructure Programs
Telephone: 301-451-7818
Email: [email protected]